Jun. 5 at 3:58 PM
$WGS: A quick FAQ on the
$21 Million GeneDx investor settlement, including eligibility and key dates.
Q: What happened?
A: CM Life Sciences which later became Sema4 and now operates as GeneDx Holdings,
$WGS, has agreed to a
$21 million settlement to resolve claims that shareholders were misled in connection with the company’s 2021 de-SPAC merger and denied a fully informed choice about redeeming their shares.
Q: Am I actually eligible?
A: If you bought
$WGS shares between July 19, 2021 and July 22. 2021 , you’re likely eligible. You don’t need to hold the stock still to claim; past losses count
Q: How much will I actually get?
A: The current estimated payout is
$0.08 per share. The final amount depends on how many people file; if fewer people claim, the payout per share can actually increase for those who did
Q: When do payouts happen?
A: Typically, within 4–9 months after the claim deadline. But the exact timing depends on the court and settlement administration.
Q: I missed the deadline. Is it too late?
A: Not necessarily! We are currently processing 'Late-but-Valid' claims. The court often accepts these as long as the fund hasn't been distributed yet.
Q: Is my data safe with 11th Estate?
A: Security is our top priority. We use bank-level encryption and are SOC2-compliant. We only process the trade data required for the court audit, and your personal financial credentials stay private.
Q: What is the fee?
A: We work on a 20% success fee. We handle the math, the paperwork, and the filing. If you don't get a payout, you don't pay us a cent.
Q: How do I start?
A: Just click the link below to submit your claim through our secure portal.
https://11th.com/cases/cmls-investor-settlement
